Home
>
National Drug Code (NDC)
>
Fosinopril Sodium
Fosinopril Sodium - 50436-3138-1 - (Fosinopril Sodium)
Drug Information of Fosinopril Sodium
| Product NDC: | 50436-3138 |
| Proprietary Name: | Fosinopril Sodium |
| Non Proprietary Name: | Fosinopril Sodium |
| Active Ingredient(s): | 20 mg/1 & nbsp; Fosinopril Sodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Fosinopril Sodium
| Product NDC: | 50436-3138 |
| Labeler Name: | Unit Dose Services |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077222 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070917 |
Package Information of Fosinopril Sodium
| Package NDC: | 50436-3138-1 |
| Package Description: | 30 TABLET in 1 BOTTLE (50436-3138-1) |
NDC Information of Fosinopril Sodium
| NDC Code | 50436-3138-1 |
| Proprietary Name | Fosinopril Sodium |
| Package Description | 30 TABLET in 1 BOTTLE (50436-3138-1) |
| Product NDC | 50436-3138 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Fosinopril Sodium |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20070917 |
| Marketing Category Name | ANDA |
| Labeler Name | Unit Dose Services |
| Substance Name | FOSINOPRIL SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
